What is NovoCure's total equity?

NovoCure (NVCR) reported total equity of $330.72M in Q1 2026.

How has NovoCure's total equity changed year-over-year?

NovoCure's total equity decreased by 8.6% year-over-year, from $361.96M to $330.72M.

What is the long-term trend for NovoCure's total equity?

Over 5 years (2020 to 2025), NovoCure's total equity has grown at a -6.5% compound annual growth rate (CAGR), from $476.53M to $340.47M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

NovoCure NVCR Total Equity

Total Equity at other companies

Boston ScientificBSX

$25.86B+16.4%

MedtronicMDT

$49.46B+3.0%

Iovance Biotherapeutics, Inc.IOVA

$721.75M-6.0%

Nuvation BioNUVB

$319.56M-23.8%

Vir Biotechnology, Inc.VIR

$812.77M-22.1%

ArriVent BioPharma, Inc.AVBP

$323.98M+60.0%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.64B-36.7%

Enterprise value$1.59B-36.3%

P/S2.4×-1.7×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's total equity?: NovoCure (NVCR) reported total equity of $330.72M in Q1 2026.
How has NovoCure's total equity changed year-over-year?: NovoCure's total equity decreased by 8.6% year-over-year, from $361.96M to $330.72M.
What is the long-term trend for NovoCure's total equity?: Over 5 years (2020 to 2025), NovoCure's total equity has grown at a -6.5% compound annual growth rate (CAGR), from $476.53M to $340.47M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.